Latest Intelligence on Company Issues in Israel

Select information type

Refine your search

Search tips

Published within

« | 1 | » »|

Type Product title / description Pub Price

Peptor: investigating additional indications in diabetes

DiaPep277 has already shown strong trial results for type I diabetes, which is in some ways similar to LADA. This makes the new investigation seem worthwhile. Approval would provide a new treatment option for an often-misdiagnosed subcategory of diabetic patients. It would also greatly increase the market potential of the drug, by allowing access to a much larger patient population.

Published By Datamonitor
15 Jan 2002

« | 1 | » »|

No help is available.